Journal of Urology Archives

February 9, 2023

Mark Cuban pharmacy could save billions on prostate cancer, bladder drugs

Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.

By Craig Boerner

December 7, 2017

Protocol reduces antibiotic use prior to cytoscopy

A study from Vanderbilt University Medical Center (VUMC) by Justin Gregg, MD, and colleagues demonstrates how a clinical protocol can help reduce unnecessary use of outpatient antibiotics.

By Paul Govern

ethnically diverse senior men being active

June 18, 2015

Vanderbilt-led study finds significant drop in new prostate cancer diagnoses

A new study led by Vanderbilt University Medical Center investigators found new diagnoses of prostate cancer in the U.S. declined 28 percent in the year following the draft recommendation from the United States Preventive Services Task Force against routine PSA screening for men.